Form 4: Calumet Inc. Director Acquires Restricted Stock Units
SEC Form 4 Filing
Director Daniel J. Sajkowski acquired 4,935 restricted stock units (RSUs) of Calumet, Inc. on November 7, 2024, which will vest on November 7, 2027.
Summary
- On November 7, 2024, Daniel J. Sajkowski, a director of Calumet, Inc., acquired 4,935 Restricted Stock Units (RSUs).
- Each RSU represents the economic equivalent of one share of Calumet, Inc. common stock with a par value of $0.01 per share.
- The RSUs are scheduled to vest on November 7, 2027, and will be settled upon vesting.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a standard disclosure of stock units being granted, which is neither overtly positive nor negative.
Positives
- The acquisition of RSUs by a director could be seen as a positive sign, indicating confidence in the company's future performance.
Future Outlook
The vesting of the RSUs in 2027 suggests a long-term incentive for the director to contribute to the company's success.
Industry Context
Form 4 filings are routine disclosures required by the SEC to ensure transparency in insider trading activities. This filing indicates a director's increased stake in the company, aligning their interests with those of shareholders.
Stakeholder Impact
- The acquisition of RSUs by a director can positively influence shareholder confidence.
Key Dates
| Date | Description |
|---|---|
| 11/07/2024 | Date of transaction: Director Daniel J. Sajkowski acquired 4,935 Restricted Stock Units. |
| 11/07/2027 | Vesting date for the 4,935 Restricted Stock Units. |
| 11/11/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.